Design Therapeutics, Inc. (DSGN) Financials

DSGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 230.4 million 12.4 million
Dec. 31, 2025 226.2 million 13.7 million
Sept. 30, 2025 211.8 million 12.1 million
June 30, 2025 222.9 million 9.8 million

DSGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -16.4 million 3.9 million
Dec. 31, 2025 -12.0 million 3.4 million
Sept. 30, 2025 -11.2 million 3.6 million
June 30, 2025 -14.5 million 4.0 million

DSGN Net Income

No data available :(

DSGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 222.8 million - 2.7 million
Dec. 31, 2025 219.8 million - 645000
Sept. 30, 2025 206.0 million - 877000
June 30, 2025 216.3 million - 1.9 million

DSGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 61.4 million
Dec. 31, 2025 57.3 million
Sept. 30, 2025 57.0 million
June 30, 2025 56.9 million

DSGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 14.4 million 5.3 million -
Dec. 31, 2025 34000 13.4 million 4.7 million -70000
Sept. 30, 2025 - 14.6 million 4.7 million 70000
June 30, 2025 87000 15.7 million 5.8 million -

DSGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -14.7 million
Sept. 30, 2025 - 14.6 million
June 30, 2025 - 152000

DSGN

Price: $10.58

52 week price:
3.33
17.25

Earnings Per Share: -1.20 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 301800

Market Capitalization: 652.1 million

Links: